Related Topics
Timing of HIV treatment during pregnancy could affect developmental delays in children
During pregnancy, the timing of when mothers start taking antiretroviral drugs to treat HIV may impact the risk of developmental delays in children, according to a study co-authored by researchers at Harvard Chan School.
What’s behind ‘shocking’ U.S. life expectancy decline—and what to do about it
U.S. life expectancy has declined to 76.4 years, the shortest it’s been in nearly two decades, according to December data from the CDC. Two experts from Harvard Chan School—Dean Michelle Williams and Ariadne Labs’ Asaf Bitton—discussed the problem…
Federal action needed to halt maternity ward closures, says expert
As maternity wards continue to close around the country, some states are implementing “bold and innovative” solutions—though none that will be as effective as federal intervention, according to Harvard Chan School’s Alecia McGregor.
African nursing leaders take deep dive into how to strengthen health systems
The inaugural cohort in the Harvard Global Nursing Leadership Program's Certificate in Global Public Health for Nurse Leaders convened in Kenya in September for a week-long intensive course on health systems strengthening.
Prenatal micronutrient supplementation could reduce noncommunicable diseases in children
Scaling up prenatal micronutrient supplementation could have population-wide benefits for the next generation.
Wafaie Fawzi, Vikram Patel, John Quackenbush elected to National Academy of Medicine
Harvard Chan School faculty members Wafaie Fawzi, Vikram Patel, and John Quackenbush were elected to the National Academy of Medicine.
Former Costa Rican President Alvarado describes his country’s public health successes
The U.S. has a lot to learn from Costa Rica. That message came through loud and clear in a fireside chat with former Costa Rican President Carlos Alvarado Quesada at Harvard Chan School.
COVID-19 medical data sharing opens window for pregnancy research
Researchers are hoping to leverage newly available data sources to answer other questions about pregnancy that have been difficult to research.
Dolutegravir-based antiretroviral therapies for HIV-1 effective in pregnancy
Dolutegravir-based antiretroviral therapies for HIV-1 are more effective for pregnant people than some other ART regimens commonly used in the U.S. and Europe, according to a new Harvard Chan School study.
Abortion restrictions raise concerns about maternal mortality risk, particularly for Black women
Given that nearly 40% of abortion patients are Black women, concerns have been raised that new restrictions on the procedure will result in more deaths in that group.